DRUG

compound 7b

3 hypotheses across 1 therapeutic domain

ALL HYPOTHESES

Repurposing candidates for compound 7b

Alzheimer 3

Mediator Outcome Score Tier Lit. status Trial
GFAP cognitive decline 0.208 Mid novel signal none
GFAP cognitive impairment 0.208 Mid novel signal none
GFAP Alzheimer disease 0.208 Mid novel signal none

Clinical trials

0 registered trials for compound 7b

Source: ClinicalTrials.gov

No registered trials found on ClinicalTrials.gov. This could indicate either an unexplored indication or a gap in registry coverage.

Search ClinicalTrials.gov →